Page 11 - Generics Access Project News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Generics access project. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Generics Access Project Today - Breaking & Trending Today

Brand name vs generics: which is more popular?

According to a Purdue University Report, most consumers would choose brand-name products over generic products, but household income impacts choices. ....

Elijah Bryant , Joseph Balagtas , Purdue University Center , Food Insights Report , Purdue University , Food Demand Analysis , Brand Belief , Next Moves , Brand Name Foods , Snack Foods ,

A hard lesson learnt: Commonwealth v Sanofi

The Australian government has made numerous claims for damages against patentees for savings forgone when an interlocutory/preliminary injunction delays generic launch but the patent is invalidated or there is a finding of non-infringement. ....

Full Federal Court , Pharmaceutical Benefits Scheme , Pearce Ip , Preliminary Injunction ,

Teva Does Not See Big Impact on Business From Israel-Hamas War

Israel s war with Hamas is not expected to have much impact on Teva Pharmaceutical Industries business performance, the company said on Tuesday. ....

Israel General , Gaza Strip , Yom Kippur , Jan Harvey , Steven Scheer , Teva Pharmaceutical Industrie , Hamas Ruled Gaza , Bill Berkrot , Practice Management , Generic Drug , Eneric Medication ,

NCCN Survey Shows Ongoing Chemo Drug Shortages

Nearly 90% of NCCN member institutions that responded to a September survey reported a shortage of at least one anticancer agent. ....

Robertw Carlson , Alyssa Schatz , National Comprehensive Cancer Network , Social Determinants Of Health , Alignant Neoplasia , Drug Shortages , Medication Shortages , Biologic Therapy , Generic Drug , Eneric Medication , Geriatrics Elder Care , Rural Health , Ural Medicine , Tropical Infection , Ropical Disease ,

Adhering to Endocrine Therapy Is Hard. What Can Be Done?

Poor adherence to adjuvant endocrine therapy remains an issue among patients with breast cancer. What can oncologists and patients do to improve long-term use? ....

New York , United States , College Park , University Of Rochester Medical Center , Hanna Weiss , Xuanzi Qin , Wilmot Cancer Center , University Of Colorado Boulder , University Of Maryland School Public Health , Colorado Boulder , Rochester Medical Center , Fixes Needed , Maryland School , Public Health , Breast Cancer , Alignant Breast Neoplasm , Dherence To Medication Issues For Patients , Endocrine Therapy , Alignant Neoplasia , Endometrial Carcinoma , Adverse Effects , Side Effects , Meta Analysis , Patient Safety , Aromatase Inhibitor , Physical Activity ,